On Friday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) opened higher 16.12% from the last session, before settling in for the closing price of $8.19. Price fluctuations for OLMA have ranged from $2.86 to $13.51 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -83.00% over the past five years. Company’s average yearly earnings per share was noted 14.05% at the time writing. With a float of $52.86 million, this company’s outstanding shares have now reached $68.63 million.
Olema Pharmaceuticals Inc (OLMA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Olema Pharmaceuticals Inc is 22.99%, while institutional ownership is 85.69%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.57) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.56% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Check out the current performance indicators for Olema Pharmaceuticals Inc (OLMA). In the past quarter, the stock posted a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.92, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -2.14 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Olema Pharmaceuticals Inc (NASDAQ: OLMA) saw its 5-day average volume 1.03 million, a positive change from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 69.68%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 99.47%, which indicates a significant increase from 98.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.63 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.19, while its 200-day Moving Average is $5.25. Nevertheless, the first resistance level for the watch stands at $9.97 in the near term. At $10.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.32. If the price goes on to break the first support level at $8.62, it is likely to go to the next support level at $7.73. Assuming the price breaks the second support level, the third support level stands at $7.27.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are currently 68,634K shares outstanding in the company with a market cap of 652.71 million. Presently, the company’s annual sales total 0 K according to its annual income of -129,470 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -43,780 K.
